Study | Health outcomes | Measurement of effectiveness | WTPa |
---|---|---|---|
Alberts et al. [36] | QALY | Cost saving | 47,438 €/QALY |
Barone et al. [34] | QALY | ICER | 60,000 €/QALY |
Barzi et al. [17] | LYG | ICER | 47,438 €/LYG |
Behl et al. [33] | LYG | ICER | 98,876 €/QALY |
Blank et al. [31] | QALY | ICER | 47,438–98,876 €/QALY (USA); 23,342–35,014 €/QALY (UK) |
Dinh et al. [27] | QALY/LYG | ICER | 47,438 €/QALY |
Gallego et al. [18] | QALY | ICER | 98,876 €/QALY |
Gausachs et al. [19] | Incremental increase in N. of cases detected | ICER | NR |
Gould-Suarez et al. [20] | Incremental increase in N. of cases detected | ICER | NR |
Gudgeon et al. [21] | Incremental increase in N. of cases detected | ICER | NR |
Ladabaum et al. [28] | LYG | ICER | 47,438 €/LYG |
Leenen et al. [22] | LYG | ICER | 40,000 €/LYG |
Severin et al. [23] | LYG | ICER | 50,000 €/LYG |
Sie et al. [24] | LYG | ICER | 80,000 €/LYG |
Snowsill et al. [27] | QALY | ICER | 23,342 €/QALY |
Snowsill et al. [25] | QALY | ICER | NR |
Vijayaraghavan et al. [32] | LYG | ICER | NR |
Wang et al. [29] | QALY | ICER | NR |
Wang et al. [30] | LYG | ICER | NR |
Westwood et al. [35] | QALY | ICER | 19,841 €/QALY |